Target
Mitogen-activated protein kinase kinase kinase kinase 1
Ligand
BDBM529744
Substrate
n/a
Meas. Tech.
TBHPK1 IC50 Assay
IC50
0.050±n/a nM
Citation
 Balan, GBartlett, MJChandrasekhar, JCodelli, JAConway, JHCosman, JLKalla, RVKasun, ZAKim, MLee, SHLo, JRLoyer-Drew, JAMitchell, SAPerry, TDPhillips, GBSalvo, PJSwaminathan, SVan Veldhuizen, JJYeung, SCZablocki, J Substituted 6-azabenzimidazole compounds US Patent  US11203591 Publication Date 12/21/2021 
Target
Name:
Mitogen-activated protein kinase kinase kinase kinase 1
Synonyms:
HPK1 | M4K1_HUMAN | MAP4K1
Type:
PROTEIN
Mol. Mass.:
91316.07
Organism:
Homo sapiens (Human)
Description:
ChEMBL_586597
Residue:
833
Sequence:
MDVVDPDIFNRDPRDHYDLLQRLGGGTYGEVFKARDKVSGDLVALKMVKMEPDDDVSTLQKEILILKTCRHANIVAYHGSYLWLQKLWICMEFCGAGSLQDIYQVTGSLSELQISYVCREVLQGLAYLHSQKKIHRDIKGANILINDAGEVRLADFGISAQIGATLARRLSFIGTPYWMAPEVAAVALKGGYNELCDIWSLGITAIELAELQPPLFDVHPLRVLFLMTKSGYQPPRLKEKGKWSAAFHNFIKVTLTKSPKKRPSATKMLSHQLVSQPGLNRGLILDLLDKLKNPGKGPSIGDIEDEEPELPPAIPRRIRSTHRSSSLGIPDADCCRRHMEFRKLRGMETRPPANTARLQPPRDLRSSSPRKQLSESSDDDYDDVDIPTPAEDTPPPLPPKPKFRSPSDEGPGSMGDDGQLSPGVLVRCASGPPPNSPRPGPPPSTSSPHLTAHSEPSLWNPPSRELDKPPLLPPKKEKMKRKGCALLVKLFNGCPLRIHSTAAWTHPSTKDQHLLLGAEEGIFILNRNDQEATLEMLFPSRTTWVYSINNVLMSLSGKTPHLYSHSILGLLERKETRAGNPIAHISPHRLLARKNMVSTKIQDTKGCRACCVAEGASSGGPFLCGALETSVVLLQWYQPMNKFLLVRQVLFPLPTPLSVFALLTGPGSELPAVCIGVSPGRPGKSVLFHTVRFGALSCWLGEMSTEHRGPVQVTQVEEDMVMVLMDGSVKLVTPEGSPVRGLRTPEIPMTEAVEAVAMVGGQLQAFWKHGVQVWALGSDQLLQELRDPTLTFRLLGSPRLECSGTISPHCNLLLPGSSNSPASASRVAGITGL
  
Inhibitor
Name:
BDBM529744
Synonyms:
US11203591, Example 151
Type:
Small organic molecule
Emp. Form.:
C42H50N8O4
Mol. Mass.:
730.8976
SMILES:
CNC(=O)c1cc(Nc2nc(cc3ncn(C4CC4)c23)-c2ccc3c(c2)N([C@H]2C[C@H](C2)N2CCCCC2)C(=O)C32CCN(CC2)C(=O)[C@@H](C)O)ccc1C |r,wU:27.30,29.35,47.56,(1.81,-9.96,;1.81,-8.42,;.48,-7.65,;-.86,-8.42,;.48,-6.11,;1.81,-5.34,;1.81,-3.8,;3.14,-3.03,;3.14,-1.49,;1.81,-.72,;1.81,.82,;3.14,1.59,;4.48,.82,;5.94,1.3,;6.85,.05,;5.94,-1.19,;6.34,-2.68,;5.94,-4.17,;7.43,-3.77,;4.48,-.72,;.48,1.59,;.48,3.13,;-.86,3.9,;-2.19,3.13,;-2.19,1.59,;-.86,.82,;-3.66,1.12,;-4.06,-.37,;-3.29,-1.7,;-4.62,-2.47,;-5.39,-1.14,;-5.02,-3.96,;-6.5,-4.36,;-6.9,-5.85,;-5.81,-6.94,;-4.33,-6.54,;-3.93,-5.05,;-4.56,2.36,;-6.1,2.36,;-3.66,3.61,;-2.57,4.7,;-2.97,6.19,;-4.45,6.58,;-5.54,5.49,;-5.14,4.01,;-4.85,8.07,;-3.76,9.16,;-6.34,8.47,;-7.43,7.38,;-6.74,9.96,;.48,-3.03,;-.86,-3.8,;-.86,-5.34,;-2.19,-6.11,)|
Structure:
Search PDB for entries with ligand similarity: